Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vaccine ; 21(13-14): 1348-54, 2003 Mar 28.
Article in English | MEDLINE | ID: mdl-12615429

ABSTRACT

The safety of the UK anthrax vaccine in British service personnel was evaluated by a retrospective cohort study of randomly selected personnel from five Royal Air Force bases by investigating adverse medical events and consultation rates for a period before and after vaccination. Vaccination acceptance rate varied from 27 to 89% (P=0.0001). In the vaccinated cohort 11.1% (n=368) reported side-effects. The number of consultations in the year prior to vaccination (P=0.04) and RAF base (P=0.0085) were associated with side-effects. Only the RAF base remained a statistically significant factor (P=0.007) after adjusting for other factors. The anthrax vaccine resulted in mild side-effects in 11%, and no serious side-effects were observed. Acceptors of vaccine did not have significantly more medical consultations following vaccination than their unvaccinated counterparts.


Subject(s)
Anthrax Vaccines/adverse effects , Military Personnel , Vaccination/adverse effects , Adult , Cohort Studies , Female , Humans , Male , Patient Acceptance of Health Care , Referral and Consultation , Retrospective Studies
2.
J Antimicrob Chemother ; 49(1): 87-94, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11751771

ABSTRACT

Antimicrobial resistance has increased over the past decade causing concern for public health. Domestic antimicrobial products containing triclosan (2,4,4'-trichloro-2'-hydroxydiphenylether), a broad-spectrum antibacterial agent, were introduced in 1997 and have become popular among consumers. Cross-resistance to other antibacterial agents has been suggested as a possible consequence of their widespread use. Triclosan-impregnated plastic storage boxes were tested for activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus and Shewanella putrefaciens in various conditions, including some designed to simulate usual storage conditions. Results showed inhibition up to a factor of 106 of bacteria grown in direct contact with triclosan-impregnated plastic at 30 and 22 degrees C, but not at 4 degrees C. Triclosan resistance was not found to increase after repeated exposure in triclosan-impregnated boxes. Further investigation into the effect of triclosan-impregnated products on bacteria will increase understanding of domestic antimicrobial products and implications of their overuse.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Bacillus cereus/drug effects , Escherichia coli/drug effects , Product Packaging , Pseudomonas aeruginosa/drug effects , Shewanella putrefaciens/drug effects , Staphylococcus aureus/drug effects , Triclosan/pharmacology , Bacillus cereus/growth & development , Colony Count, Microbial/methods , Colony Count, Microbial/statistics & numerical data , Escherichia coli/growth & development , Product Packaging/methods , Product Packaging/statistics & numerical data , Pseudomonas aeruginosa/growth & development , Shewanella putrefaciens/growth & development , Staphylococcus aureus/growth & development , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...